Clinical Trial Update: Valbenazine in Obsessive Compulsive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is planned to study valbenazine for obsessive-compulsive disorder; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Valbenazine (valbenazine)

Snippet

Sponsor: University of Chicago | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: NOT_YET_RECRUITING